Study at a glance
How did different forms of vitamin D attach inside chick gland cells?
Researchers used tissue from the parathyroid glands of chicks with vitamin D deficiency. In the laboratory, they separated material from inside and outside the cell nucleus, the part containing genetic information. They studied how strongly different forms of vitamin D attached to substances in these samples. This was a study of cell components, not a treatment trial in people.
What did they find about active vitamin D?
The active form, called 1alpha,25-dihydroxyvitamin D3, attached strongly to certain substances found both inside and outside the nucleus. These substances preferred the active form over other vitamin D forms. Their similar physical properties suggested that the same type of substance was present in both locations. This behaviour resembled that of receptors, which receive chemical signals.
Did another form of vitamin D attach in the same places?
A separate group of substances preferred 25-hydroxyvitamin D3, another form of vitamin D. These substances had different physical properties and appeared in more types of tissue. They were not found in the nucleus under the conditions tested. The two forms of vitamin D therefore did not attach to cell components in the same way.
Does vitamin D attaching inside a cell prove that it changes cell activity?
The findings support a possible way for active vitamin D to send signals inside cells. They do not show that particular genes were activated, that protein production changed or that health improved. Finding an attachment in the nucleus does not prove those effects. Results from separated cell components in chicks do not describe every tissue, species or person.
Read the full article below ↓This page provides an expanded, derived summary of a single verified primary study examining how the active vitamin D metabolite interacts with intracellular macromolecular components in a way consistent with hormone-like cellular signalling. The focus is on binding specificity, affinity, subcellular localisation, and the structural features of the binding components as observed in a defined experimental system.
Study identity
Study type: Primary molecular and cellular binding study (competitive binding, cytosol/nuclear fractionation, sedimentation and gel filtration characterisation)
Population or system studied: Parathyroid glands from vitamin D-deficient chicks (tissue cytosol and nuclear fractions analysed in vitro)
Primary exposure or variable: 1alpha,25-dihydroxyvitamin D3 binding to macromolecular components in cytoplasm and nucleus
Primary outcome category: Presence, specificity, affinity, and subcellular distribution of binding components consistent with a receptor-mediated signalling mechanism
Purpose of the study
The study aims to test whether the active vitamin D metabolite, 1alpha,25-dihydroxyvitamin D3, interacts with discrete macromolecular binding components in target tissue in a manner consistent with regulated cellular signalling. Rather than treating vitamin D action as a diffuse biochemical effect, the paper asks whether there are identifiable binding entities with hallmark properties of hormone receptors: high affinity, ligand preference, and tissue-selective presence. This purpose matters because receptor-like binding is a mechanistic prerequisite for controlled signalling, especially for pathways that ultimately influence gene regulation and endocrine feedback.
A second, closely linked purpose is to distinguish potentially different classes of binding components for different vitamin D metabolites within the same tissue. The paper does not assume that all vitamin D-related sterols share the same binding machinery; instead, it investigates whether binding entities differ in sedimentation behaviour, tissue distribution, ligand preference, and subcellular localisation. That separation is central to interpreting “signalling mechanisms” correctly, because it prevents conflation of a high-affinity signalling interaction with more general transport-like or ubiquitous binding behaviour that may not represent a dedicated signalling receptor.
Study overview
Using parathyroid glands from vitamin D-deficient chicks, the investigators prepared cytosolic and nuclear fractions and assessed the binding of 1alpha,25-dihydroxyvitamin D3 to macromolecular components. Binding was evaluated for affinity and specificity using competitive displacement, and subcellular distribution was assessed by examining whether hormone: macromolecule complexes could be detected in both cytoplasm and nucleus. This design targets a core signalling claim: that the active ligand forms a complex with a macromolecular partner and that this complex is present in the nucleus, a location consistent with regulated genomic action even if direct gene regulation is not measured in the same experiment.
The study then characterises the observed binding components using sedimentation in sucrose gradients and size estimation by agarose gel filtration. These methods provide a physical description of the binding entities, helping to determine whether cytoplasmic and nuclear binding behave as the same class of molecule and whether other binding components with different properties coexist in the tissue. The analysis explicitly compares the receptor-like binding component for 1alpha,25-dihydroxyvitamin D3 with a distinct macromolecular species showing preference for 25-hydroxyvitamin D3, reinforcing that different metabolites can be associated with different binding behaviours and potentially different biological roles.
Finally, the study considers tissue selectivity by examining whether the same 1alpha,25-dihydroxyvitamin D3 binding component appears across multiple tissues. This aspect is conceptually important: signalling receptors are often enriched in target tissues and absent or minimal in non-target tissues, whereas ubiquitous binding components suggest more general functions. The paper therefore frames its findings as consistent with target-tissue action and endocrine regulation, while maintaining boundaries around what can and cannot be concluded from binding evidence alone.
Key findings
The study reports specific binding of 1alpha,25-dihydroxyvitamin D3 to macromolecular components in both cytoplasmic and nuclear fractions of chick parathyroid glands. The binding is described as high affinity, with competitive specificity indicating a strong preference hierarchy in which 1alpha,25-dihydroxyvitamin D3 competes more effectively than other vitamin D-related sterols. This finding is central to signalling interpretation because high-affinity, ligand-preferential binding is a defining receptor-like property rather than a feature of nonspecific partitioning into lipids or incidental association with abundant proteins.
Both cytoplasmic and nuclear hormone: macromolecule complexes exhibit similar sedimentation behaviour (reported at approximately 3.1S under the described conditions), and gel filtration suggests an apparent molecular weight in a defined range for these binding molecules. The alignment between cytoplasmic and nuclear complex properties supports the interpretation that the same class of binding component is involved across compartments, consistent with a signalling pathway in which ligand binding leads to nuclear association of a receptor complex. While the study does not measure transcriptional outcomes directly, nuclear presence is treated as mechanistically relevant because it provides a plausible route for regulated cellular responses.
The study also identifies a second class of macromolecular species in parathyroid cytosol with a higher affinity and preference for 25-hydroxyvitamin D3. These species differ from the 1alpha,25-dihydroxyvitamin D3 binding component in sedimentation behaviour, tissue distribution, ligand preference, and nuclear presence. The distinction matters because it prevents the signalling interpretation from being diluted by ubiquitous binding: the paper explicitly notes that the 25-hydroxyvitamin D3-preferring species are observed across many tissues examined and are not found in the nucleus in vitro, contrasting with the more target-associated and nuclear-linked behaviour of the 1alpha,25-dihydroxyvitamin D3 binding component.
Conceptual significance
The conceptual value of this study is that it ties “active vitamin D” to an intracellular binding interaction with properties characteristic of hormone signalling. In physiology-first terms, this shifts interpretation away from vitamin D metabolites acting only through bulk biochemical effects and toward an architecture in which a specific active ligand interacts with a macromolecular partner that is not uniformly distributed across tissues and that is detectable in nuclear fractions. Even without direct gene-expression assays, the combination of high-affinity ligand preference and nuclear association provides mechanistic infrastructure consistent with controlled, receptor-mediated signalling.
Equally important, the study illustrates why metabolite identity matters for signalling interpretation. It does not treat 25-hydroxyvitamin D3 and 1alpha,25-dihydroxyvitamin D3 as interchangeable variants; instead, it shows that different metabolites can correspond to binding components with different sedimentation behaviour, tissue distribution, and subcellular localisation. That separation supports a layered physiology model: upstream metabolites may participate in broader distribution or binding phenomena, while the hormonally active form engages a more specialised signalling interface in target tissues.
What this study shows
This study shows that, in an experimental system using parathyroid glands from vitamin D-deficient chicks, 1alpha,25-dihydroxyvitamin D3 forms high-affinity, specific complexes with macromolecular binding components detectable in both cytosolic and nuclear fractions. It further shows that these binding components have definable physical properties by sedimentation and size estimation, and that their behaviour differs from other macromolecular species in the same tissue that preferentially bind 25-hydroxyvitamin D3 and appear to be more widely distributed across tissues. Together, these findings support the interpretation that active vitamin D signalling can be mediated by specialised intracellular binding components consistent with receptor-like behaviour.
What this study does not show
The study does not directly demonstrate downstream gene regulation, changes in transcription, protein expression, or organism-level physiological outcomes resulting from the binding interactions it measures. It also does not establish the full signalling cascade, identify DNA response elements, or characterise co-regulators that participate in vitamin D receptor action in modern frameworks. Tissue fractionation and binding characterisation cannot, by themselves, prove that nuclear-associated ligand binding produces a specific transcriptional programme, only that a mechanistically plausible receptor-like interaction exists and is detectable in nuclear fractions under the conditions tested.
Limitations (high level)
The work is based on an in vitro analysis of binding components in tissue fractions rather than a direct demonstration of functional outcomes in intact organisms. Subcellular fractionation and binding assays can establish specificity, affinity, and localisation, but they do not fully resolve whether the nuclear complex is engaged with genomic targets or how signalling dynamics unfold over time. Additionally, findings are reported in a specific physiological and experimental context (vitamin D-deficient chicks, parathyroid tissue), so the results should be interpreted as mechanistic evidence within that context rather than as a complete map of vitamin D signalling in all tissues or species.
Interpretation within vitamin D physiology
Within the physiology of how vitamin D3 works, this study contributes to the “cellular signalling” layer by providing evidence that the active metabolite interacts with intracellular macromolecular binding components that meet key receptor-like criteria: high affinity, ligand preference, and detection in nuclear fractions. In a stepwise view of the vitamin D system, metabolic activation produces an active ligand whose physiological meaning depends not only on presence but on engagement with a signalling interface inside target tissues. The distinction this paper makes between a specialised 1alpha,25-dihydroxyvitamin D3 binding component and a more widely distributed 25-hydroxyvitamin D3-preferring species reinforces the idea that different metabolites occupy different functional layers, and that “activity” should be interpreted in relation to which binding components are engaged, where they are found, and what subcellular compartments they occupy.
For relevant physiology background, see How Vitamin D3 Works.
Relevant physiology background: Vitamin D Receptors.
Primary source and publication details
Brumbaugh PF, Hughes MR, Haussler MR, et al.
Cytoplasmic and nuclear binding components for 1alpha,25-dihydroxyvitamin D3 in chick parathyroid glands.
Proc Natl Acad Sci U S A. 1975.
DOI: 10.1073/pnas.72.12.4871
https://pubmed.ncbi.nlm.nih.gov/1061076
For deeper study-specific detail, see Cellular Signalling Mechanisms of Active Vitamin D: Full Evidence Review.
Related reading
Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signaling mechanisms
Evidence suggests that there are aberrations in the vitamin D-endocrine system in subjects with amyotrophic lateral sclerosis (ALS).
Original paper ↗Read more →Cellular Signalling Mechanisms of Active Vitamin D: Full Evidence Review
A full evidence review examining how active vitamin D signals at the cellular level, including receptor binding, transcriptional control, and physiological constraints.
Read more →VDR/RXR Signalling and Gene Regulation: Full Evidence Review
How receptor knockout and genomic analyses distinguish VDR-dependent transcription, predicted direct targets and secondary responses in human monocytic cells.
Read more →Decoding Diabetes Biomarkers and Related Molecular Mechanisms by Using Machine Learning, Text Mining, and Gene Expression Analysis
We aimed to identify the most frequently reported and differential expressed genes (DEGs) in diabetes by using bioinformatics approaches.
Original paper ↗Read more →Differential gene regulation by a synthetic vitamin D receptor ligand and active vitamin D in human cells
Vitamin D (VD) exerts a wide variety of biological functions including calcemic activity.
Original paper ↗Read more →VDR/RXR Signalling and Gene Regulation: Study Summary
A summary of receptor-dependent gene regulation, early and late responses, and the limits of a vitamin D signalling study in cultured human monocytic cells.
Read more →Comparing Gene Expression in the Parabrachial and Amygdala of Diestrus and Proestrus Female Rats after Orofacial Varicella Zoster Injection
The expression of genes in the parabrachial and amygdala in diestrus (low estradiol) and proestrus (high estradiol) female rats were evaluated in this study.
Original paper ↗Read more →Decreased inflammatory gene expression accompanies the improvement of liver enzyme and lipid profile following aerobic training and vitamin D supplementation in T2DM patients
In this study, 40 male T2DM patients aged 35 to 50 years were randomly selected and assigned into four groups (n = 10 for each); AT+vitamin D supplementation (AT+Vit D), AT+placebo (AT), Vit D supplementation (Vit D), and control+placebo (C).
Original paper ↗Read more →Differential and Overlapping Effects of 20,23(OH)2D3 and 1,25(OH)2D3 on Gene Expression in Human Epidermal Keratinocytes: Identification of AhR as an Alternative Receptor for 20,23(OH)2D3
A novel pathway of vitamin D activation by CYP11A has previously been elucidated.
Original paper ↗Read more →Effects of supplemental 25-hydroxyvitamin D3 on growth performance, physiological responses, and gene expression of skeletal muscle growth of finishing beef cattle
The objective of this experiment was to evaluate the effects of 25-hydroxyvitamin D3 (25(OH)D3) supplementation on growth performance, carcass characteristics, meat quality, and the expression of genes related to anabolism of skeletal muscle in finishing beef cattle.
Original paper ↗Read more →Effects of vitamin D supplementation on alveolar macrophage gene expression: preliminary results of a randomized, controlled trial
The objective of this study was to determine the effects of vitamin D supplementation on gene expression of alveolar macrophages.
Original paper ↗Read more →Improvement in the Immunity: and Vitamin D3-Activity-Related Gene Expression of Coccidiosis-Challenged Ross 708 Broilers in Response to the In Ovo Injection of 25-Hydroxyvitamin D3 †
Effects of the in ovo administration of two vitamin D3 sources (vitamin D3 (D3) and 25-hydroxyvitamin D3 (25OHD3)) on the expression of D3 activity: and immunity-related genes in broilers subjected to a coccidiosis infection were investigated.
Original paper ↗Read more →Investigating the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors
This study aimed to investigate the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors.
Original paper ↗Read more →Peripheral T-Cells, B-Cells, and Monocytes from Multiple Sclerosis Patients Supplemented with High-Dose Vitamin D Show Distinct Changes in Gene Expression Profiles
We collected peripheral blood mononuclear cells from participants at baseline and again after six months of treatment.
Original paper ↗Read more →The Evidence That 25(OH)D3 and VK2 MK-7 Vitamins Influence the Proliferative Potential and Gene Expression Profiles of Multiple Myeloma Cells and the Development of Resistance to Bortezomib
The aim of the study was to evaluate the effect of BTZ therapy and VD and VK supplementation on the proliferation potential and gene expression profiles of MM cells in terms of the development of BTZ resistance.
Original paper ↗Read more →Tissue-Specific VDR Pathway Gene Expression Is Not Associated with Circulating 25OHD in Adolescents with Severe Obesity
This study examined the expression patterns of VDR-target genes across metabolically diverse tissues and compared these molecular measures with circulating serum 25-hydroxyvitamin D (25OHD), the current clinical marker of vitamin D status.
Original paper ↗Read more →Vitamin D and IFN-β Modulate the Inflammatory Gene Expression Program of Primary Human T Lymphocytes
IFN-β treatment is a commonly used therapy for relapsing-remitting multiple sclerosis (MS), while vitamin D deficiency correlates with an increased risk of MS and/or its activity.
Original paper ↗Read more →Vitamin D deficiency in mice modulates oral microbiome stability over time and leads to changes in host inflammatory gene expression pathways
To understand the relationship between vitamin D, the oral microbiome, and host factors, we performed taxonomic profiling of the oral microbiome from C57Bl/6 mice fed either a vitamin D-deficient diet or a standard diet.
Original paper ↗Read more →Vitamin D supplementation in systemic lupus erythematosus: relationship to disease activity, fatigue and the interferon signature gene expression
The aim of this prospective open-label study was to assess the effect of the treatment of vitamin D deficiency and insufficiency in SLE patients, particularly with regards to disease activity, fatigue and interferon signature gene expression.
Original paper ↗Read more →Vitamin D and Lasting Gene Regulation: Full Evidence Review
Can vitamin D signalling leave lasting changes in gene regulation?
Read more →Vitamin D-Responsive Gene Expression Across Cells and Tissues: Full Evidence Review
Compare vitamin D-responsive transcription in cells, organoids and human blood, with distinctions between acute signals, longer trials and tissue outcomes.
Read more →Original sources
https://pubmed.ncbi.nlm.nih.gov/1061076
https://pubmed.ncbi.nlm.nih.gov/1061076.
Publication details
https://pubmed.ncbi.nlm.nih.gov/1061076